OpGen (NASDAQ:OPGN) Receives New Coverage from Analysts at StockNews.com

StockNews.com started coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a report released on Saturday. The brokerage issued a sell rating on the medical research company’s stock. OpGen Stock Performance OPGN stock opened at $3.30 on Friday. OpGen has a one year low of $1.65 and a one year high of $38.40. The […]

Leave a Reply

Your email address will not be published.

Previous post Brokers Set Expectations for AutoZone, Inc.’s FY2024 Earnings (NYSE:AZO)
Next post NantHealth (NASDAQ:NH) Earns Hold Rating from Analysts at StockNews.com